![]()
MIRA INFORM REPORT
|
Report Date : |
09.03.2011 |
IDENTIFICATION DETAILS
|
Name : |
SO PRO PHA SARL |
|
|
|
|
Registered Office : |
BP E 3969 |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
01.04.2004 |
|
|
|
|
Legal Form : |
Societe Anonyme A Responsabilite Limitee |
|
|
|
|
Line of Business : |
Importers and distribution
of pharmaceuticals and allied products
|
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
20,000 USD |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment
Behaviour : |
Slow |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2010
|
Country Name |
Previous Rating (30.09.2010) |
Current Rating (31.12.2010) |
|
|
b2 |
b2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
COMPANY REPORTED: |
SO PRO PHA SARL |
|||
|
Other Names: |
SOCIETE DES PRODUITS
PHARMACEUTIQUES SARL |
|||
|
Principal Address: |
BP E 3969 |
|||
|
Telephone: |
+223-20218944/ 20233639 |
|||
|
Fax: |
+223 -2218944 |
|||
|
Email: |
none |
|||
|
Internet: |
none |
|||
|
Established: |
01/04/2004 |
|||
|
Registration: |
|
|||
|
Legal Form: |
Societe Anonyme A Responsabilite Limitee |
|||
|
Stock Listing: |
Not Listed |
|||
|
Workforce: |
2010 |
|
|
|
|
|
145 |
|
|
|
|
Office &
Factories |
|
|||
|
Head offices |
Zone industrielle bougouba. |
|||
|
Branches |
none |
|||
Current Credit Limit: 20,000 USD
Management/ Directors
President/ CEO (1)
Name Deepak Moolchandani
Active in daily business: Active
Current Title: Director
Country of residence
Remarks Top Decision Maker
̃ Top decision maker is the person who has the
ultimate authority or power to make important managerial decisions. He/She may
or may not be officially registered as a president or an executive director.
No negative information found.
|
Company Profile: |
|
||
|
Nominal Capital |
CFA. 100,000,000 |
||
|
Shareholders |
|
||
|
Name |
Position |
Amount
|
Ratio |
|
Deepak Moolchandani |
Director |
|
|
|
Bernard Sanou |
Manager |
|
|
|
Total |
|
|
100.00% |
Terms of payment
Buying terms 30%
in cash, 70% on credit
Selling terms 80% in cash, 20% on credit
Recent Sales CFA. 820,000,000 (Estimated 2010)
Exports None
Export Ratio 10.0%
Import Ratio
Domestic Market
Share 20.0%
Affiliated Companies None
No financial statement to disclosed.
Business Activities Importers
and distribution of pharmaceuticals and allied products
Suppliers Various
Customers Distribution
agencies , hospitals, Pharmaceutical stores and outlets
Business Premises 10,000
Sft
Type of
occupation Rented
Location The
subject is located close to a major road network
Premises used
as Offices, Warehouse,
Workshop
Banking relationship
Main Banks Eco Bank
(as of report date)
Payment Morale: In the documents at our disposal nothing
adverse has been shown so far.
CREDIT RATING: Financial situation is average.
Na
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.03 |
|
|
1 |
Rs.72.98 |
|
Euro |
1 |
Rs.62.94 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.